NIVEGU.KNOW BEFORE YOU FLY

THE WORLD OF AVIATION.
YOUR JOURNEY, EXPLAINED.

Search Plan my trip
NASDAQ / LIVE COMPANY INTELLIGENCE

Royalty Pharma plc

Nasdaq-listed company. Follow earnings, filings, products, capital and the competitive forces moving the company.

TICKERRPRX
CORENasdaq-listed company
WATCHEarnings + filings + operating news
STATUSContinuously updated
LIVE / RPRX COVERAGE

What’s moving Royalty Pharma plc now

Current reporting with the operating signal separated from the noise.

01
Investing.com India

Form 144 Royalty Pharma plc For: 29 September By Investing.com

The story matters when it changes Royalty Pharma plc’s customers, execution, competitive position or capital requirements.

Watch next: confirmation in a company filing, official release or regulator record.
02
Royalty Pharma Plc (RPRX)

Royalty Pharma Plc (RPRX)

The story matters when it changes Royalty Pharma plc’s customers, execution, competitive position or capital requirements.

Watch next: confirmation in a company filing, official release or regulator record.
03
Investing.com Nigeria

Form 144 Royalty Pharma PLC For: 27 September By Investing.com

The story matters when it changes Royalty Pharma plc’s customers, execution, competitive position or capital requirements.

Watch next: confirmation in a company filing, official release or regulator record.
04
Investing.com India

Form 4 Royalty Pharma Plc For: 25 September By Investing.com

The story matters when it changes Royalty Pharma plc’s customers, execution, competitive position or capital requirements.

Watch next: confirmation in a company filing, official release or regulator record.
05
Yahoo Finance UK

Royalty Pharma plc (RPRX) stock price, news, quote and history

Investors are testing whether Royalty Pharma plc’s operating performance supports its strategy and valuation.

Watch next: the filing, cash flow, guidance and capital-expenditure plan.
06
TipRanks

Royalty Pharma PLC (RPD) Q1 2025 Earnings Report - Results, Call & Slides

Investors are testing whether Royalty Pharma plc’s operating performance supports its strategy and valuation.

Watch next: the filing, cash flow, guidance and capital-expenditure plan.
07
MarketBeat

Andra AP fonden Lowers Stock Holdings in Royalty Pharma PLC $RPRX

Investors are testing whether Royalty Pharma plc’s operating performance supports its strategy and valuation.

Watch next: the filing, cash flow, guidance and capital-expenditure plan.
08
TipRanks

Royalty Pharma PLC (RPD) Q4 2025 Earnings Report - Results, Call & Slides

Investors are testing whether Royalty Pharma plc’s operating performance supports its strategy and valuation.

Watch next: the filing, cash flow, guidance and capital-expenditure plan.
09
TipRanks

Royalty Pharma PLC (RPD) Q4 2024 Earnings Report - Results, Call & Slides

Investors are testing whether Royalty Pharma plc’s operating performance supports its strategy and valuation.

Watch next: the filing, cash flow, guidance and capital-expenditure plan.
10
Class A

Royalty Pharma plc - Ordinary Shares

Investors are testing whether Royalty Pharma plc’s operating performance supports its strategy and valuation.

Watch next: the filing, cash flow, guidance and capital-expenditure plan.
11
Royalty Pharma plc (RPRX) vs. AstraZeneca PLC (AZN): Which Biopharma Model Offers the Better Growth Story?

Royalty Pharma plc (RPRX) vs. AstraZeneca PLC (AZN): Which Biopharma Model Offers the Better Growth Story?

The story matters when it changes Royalty Pharma plc’s customers, execution, competitive position or capital requirements.

Watch next: official volume, pricing, inventory and segment margin.
12
Royalty Pharma PLC (RPRX) hits fresh high: Is there still room to run?

Royalty Pharma PLC (RPRX) hits fresh high: Is there still room to run?

The story matters when it changes Royalty Pharma plc’s customers, execution, competitive position or capital requirements.

Watch next: confirmation in a company filing, official release or regulator record.
PRIMARY DOCUMENTS / SEC EDGAR

Latest RPRX filings.

Investor-relevant reports are shown first, followed by the company’s other recent official submissions.

10-QQuarterly financial reportFiled 2026-08-05 · Period 2026-06-30SEC ↗10-QQuarterly financial reportFiled 2026-05-06 · Period 2026-03-31SEC ↗10-KAnnual financial reportFiled 2026-02-11 · Period 2025-12-31SEC ↗8-KMaterial company eventFiled 2026-08-05 · Period 2026-08-05SEC ↗8-KMaterial company eventFiled 2026-06-04 · Period 2026-06-04SEC ↗8-KMaterial company eventFiled 2026-05-28 · Period 2026-05-22SEC ↗DEF 14AProxy and shareholder meetingFiled 2026-04-10 · Period 2026-06-04SEC ↗144Official SEC filingFiled 2026-09-28SEC ↗
EARNINGS / QUARTERLY TRACKER

Royalty Pharma plc, quarter by quarter.

Results, guidance and earnings coverage are grouped only when the source headline identifies the reporting period.